“hepatitis-c” Archives

in
Entry Author Date Location
Gilead Makes Long-Awaited Splash With $12B Bet on Kite, Cell Therapy 08/28/17 San Francisco
Report: Martin Shkreli Faces Prison Term After Fraud Conviction 08/04/17 New York
Bio Roundup: Obamacare Persists, FDA Approves, Vertex Wows & More 07/21/17 National
Regulus Dumps Two Drugs, AstraZeneca Sends Back Another, Shares Fall 06/12/17 San Diego
Vertex Bags Concert’s Rival CF Drug For $160M, Plans Combo Studies 03/06/17 Boston
Bio Roundup: Tom Price, Patient Conflicts, Orphan Games & More 01/20/17 National
Vertex Deals Cancer Drugs to Merck KGaA for $230M, Following Plan 01/11/17 Boston
Families Fret As Insurers Mull Biogen’s $750K Spine Disease Drug 01/06/17 National
Wake Up, Pharma—Trump Is Not Your Savior 12/08/16 Boston
After “Hubris” and Its HCV Collapse, Can Vertex Avoid Same Mistakes? 10/18/16 Boston
How Doctors Think About Drug Prices 10/11/16 Boston
Biotech Roundup: Gilead Slump, Celgene Goes Trump, Hemo Data & More 07/29/16 National
Biotech Roundup: Fighting Addiction, Obama Precision, Juno Deaths & More 07/08/16 National
KaloBios Deals With Shkreli After Exiting Bankruptcy With New Cash 07/07/16 San Francisco
Regulus Shares Crumble As FDA Halts Testing of Hepatitis C Drug 06/27/16 San Diego
Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More 06/10/16 National
East Coast Biotech Roundup: Harvard’s Haul, Patent Fights, Padlock & More 03/24/16 Boston
West Coast Bio Roundup: CRISPR Patent, HCV Data, Verily Digs & More 02/19/16 San Francisco
East Coast Biotech Roundup: Editas, Hep C, Akashi, Tarveda & More 01/29/16 Boston
Innovation vs. Healthcare Spending: Biotech’s Biggest Looming Challenge 12/28/15 National
West Coast Bio Roundup: Shkreli Cuffed, KaloBios Halted & More 12/17/15 National
Biogen Helps Put $42.5M Into a Father’s Duchenne Gene Therapy Quest 11/05/15 Boston
Pharma Plays The “Value” Card: Drug Spending Then And Now 09/14/15 National
FDA Approves Vertex’s Two-Drug Combo For Cystic Fibrosis 07/02/15 Boston
Vertex Teams up With Durham’s Parion in $80M Lung Drug Deal 06/04/15 Boston
East Coast Biotech Roundup: Bluebird, Sarepta, Synlogic & More 05/22/15 Boston
West Coast Biotech Roundup: Orexigen, Denali, Nant, ASCO & More 05/15/15 San Diego
FDA Panel Backs Vertex’s Two-Drug Combo For Cystic Fibrosis 05/12/15 Boston
The Innovation Challenge: Assessing BioPharma Startups 05/04/15 Seattle
Reflections on the “Build to Buy,” Part 2: The Applicability Problem 04/30/15 National
Page 1 of 10 next page »